The main outcomes of the m-Resist project can be summarised as follows:

m-Resist innovative clinical interventions for patients and caregivers

  • Novel and unique, therapeutic mHealth-based intervention is designed for patients with treatment-resistant schizophrenia. This program makes possible for the patient group to utilize modern technology as one part of their care. These interventions determine the flow of information and interactions between the user and the system according to two categories: basal modules (Treatment Adherence, Healthy Lifestyle, and Symptom Management-CBTp) oriented to develop abilities in the patient; and Risk modules (Symptom Management-Risk), oriented to deal with specific problems in risk situations.

m-Resist innovative clinical interventions for staff and professionals

  • These interventions help the staff and people being in clinical responsibility to communicate directly and rapidly with the patient and manage their care. Main focus is the clinical follow-up of psychiatric and somatic disorders, medication monitoring, and early detection and intervention in critical situations. 

m-Resist innovative mHealth system

  • The m-Resist system is composed by three main parts: a smartphone connected to a smartwatch for patients and caregivers; a web-based dashboard for follow-up and monitoring for clinicians; and a back-end system for managing data, interventions and interactions between users, which is composed by different modules (Clinical Decision Support System-CDSS, m-RESIST Information Repository-mIR, Recommender Module, Predictive Module, Sensor Analysis Module and Integration Layer).

The m-Resist is designed to be used by patients, caregivers and clinicians. The protocol within m-Resist project, encourages patients with Treatment-Resistant Schizophrenia to engage in their health care, helps caregivers play a more active role in the treatment, and provides clinicians with a remote monitoring tool to make clinical decisions.